PETER HUGH: Open Payments
NPI 1316035082 · LAKEWOOD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$548 in 20 payments from 13 companies in 2025. Trend: 2023 $845 · 2024 $647 · 2025 $548
Food & beverage: $548
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $91 |
| GlaxoSmithKline, LLC. | 3 | $85 |
| Phathom Pharmaceuticals, Inc. | 2 | $77 |
| Abbott Laboratories | 1 | $53 |
| PFIZER INC. | 2 | $49 |
| ABIOMED | 1 | $33 |
| Sumitomo Pharma America, Inc. | 1 | $30 |
| Exact Sciences Corporation | 1 | $28 |
| Amgen Inc. | 1 | $26 |
| Novo Nordisk Inc | 1 | $22 |
Products named: VOQUEZNA, FARXIGA, TRELEGY ELLIPTA, ID NOW INSTRUMENT, PREVNAR 20, GEMTESA, Cologuard Collection Kit, Otezla.
Industry payments across CA — which companies pay providers there.
